本文選題：微小分子RNA + 子宮頸癌�。� 參考：《中國婦產(chǎn)科臨床雜志》2015年02期

【摘要】：目的探討微小分子RNA(microRNA-21,miR-21)在宮頸癌患者組織中的表達情況。方法選擇宮頸鱗癌20例作為宮頸癌組,其中12例HPV16陽性,8例HPV16陰性;正常宮頸16例作為對照組,采用實時定量PCR方法檢測miR-21在各組中的表達情況。結(jié)果 MiR-21在宮頸癌和對照組中的相對表達量為4.019±0.002;MiR-21在HPV16陽性宮頸癌組和陰性組的相對表達量分別為2.376±0.034和2.002±0.024,差異有統(tǒng)計學意義(P0.05)。結(jié)論 miR-21在宮頸癌組織中呈高表達,可能與宮頸癌發(fā)生、發(fā)展有關(guān)。
[Abstract]:Objective to investigate the expression of microRNA-21 miR-21 in patients with cervical cancer. Methods Twenty cases of cervical squamous cell carcinoma were selected as cervical cancer group, of which 12 cases were HPV16 positive and 8 cases were HPV16 negative, and 16 cases of normal cervix as control group. The expression of miR-21 in each group was detected by real-time quantitative PCR. Results the relative expression of MiR-21 in cervical carcinoma and control group was 2.376 鹵0.034 and 2.002 鹵0.024, respectively (P 0.05). Conclusion there is a high expression of miR-21 in cervical carcinoma, which may be related to the occurrence and development of cervical cancer.
【作者單位】： 上海交通大學附屬第六人民醫(yī)院南院婦科微創(chuàng);
【基金】：上海市奉賢區(qū)科委資助項目(2012-1003)
【分類號】：R737.33

【相似文獻】

相關(guān)期刊論文 前10條

1 賴年鈺;喻W，

本文編號：1899836